The recent article by DeCarli et al 1 addresses a somewhat neglected aspect of white matter hyperintensities (WMH), the significance of their anatomical location. The authors argue that the commonly accepted categorization into deep (DWMH) and periventricular (PVWMH) WMH is arbitrary, because the 2 are very highly correlated, and a spatial analysis does not reveal distinct populations. We think that this conclusion is premature, because the categorization depends on a number of factors. The first limitation of their analysis is that they examined individuals in their 70s who presented to a specialty clinic, suggesting that the white matter lesions in their sample were at an advanced stage. If an analogy is drawn from cerebral atrophy in dementia, regional differences in atrophy that are present in the different subtypes of dementia become less prominent in the later stages. In our study of WMH in middle age (60 to 64 years), the correlation of DWMH and PVWMH was much lower (rϭ0.621; PϽ0.001; nϭ477), accounting for Ͻ40% of the variance. 2 It is possible that the 2 subtypes of WMH have different but converging trajectories, possibly because of overlapping but not identical risk factors and pathogenesis. Neuropathological differences between DWMH and PVWMH have been reported, 3 which suggest that whereas cerebral ischemia is a common etiological factor, other mechanisms may be differentially involved. In our study, hypertension was a risk factor for both, but diastolic blood pressure (BP) correlated significantly with DWMH, whereas both systolic and diastolic BP were correlated with PVWMH. 4 Homocysteine was a determinant of DWMH but not PVWMH, 5 but lung capacity was more strongly related to PVWMH. 6 The functional significance of the 2 subtypes is also likely to be different. In an earlier study involving stroke patients, 7 we showed that although DWMH accounted for only one third of the total WMH volume, with the other two thirds being PVWMH, it had a stronger relationship with cortical perfusion. Our recent analysis of data from 397 community-based middleaged individuals suggests that DWMH have a significant relationship with cortical atrophy (rϭ0.15; Pϭ0.003) and ventricular dilatation (rϭ0.18, PϽ0.0005), but PVWMH do not (rϭ0. 06, Pϭ0.21; rϭϪ0.03, Pϭ0.56 respectively. 8 There are also demonstrated differences in the effect of DWMH or PVWMH on cognitive function, motor function, 9 and emotions. 10 Therefore, we support the continuing distinction between DWMH and PVWMH, at least for research. In fact, additional anatomical categorization into lobar and arterial territorial regions may be relevant for some purposes. To lump all of the WMH into 1 category will hamper our understanding of their pathogenesis and functional relevance. Christenson H, Jorm AF. Pulmonary function, cognitive impairment and brain atrophy in a middle aged community sample. Dement Geriatr Cogn Disord. 2005; in press. 7. Wen W, Sachdev P, Shnier R, Brodaty H. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI. NeuroImage. 2004;21:1350 -1356. Wen W, Sachdev PS, Chen X. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage. 2005; in press. 9. Sachdev PS, Wen W, Christensen H, Jorm AF. White matter hyperintensities are related to physical disability and poor motor function.
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